Quironsalud Madrid
| Turchia | Austria | Spagna | |
| Terapia con Actinio-225 | da $22,955 | da $55,000 | da $45,000 |
| Immunoterapia con Keytruda (Pembrolizumab) | da $3,300 | da $15,000 | da $15,000 |
| Chirurgia micrografica di Mohs | da $2,200 | da $4,000 | da $2,200 |
| Chirurgia del melanoma | da $3,500 | da $9,500 | da $4,500 |
| Terapia topica del melanoma | da $1,450 | - | da $6,410 |
Il medico è uno specialista in Dermatologia Medico-Chirurgica con oltre 45 anni di esperienza. Come Responsabile Clinico di Dermatologia presso l'Hospital de Sant Pau e Direttore dell'Unità Mohs presso l'Università Autonoma di Barcellona, il medico è stato un pioniere nel campo dell'oncodermatologia.
Con competenze nella Prevenzione, Diagnosi e Trattamento del Cancro della Pelle, il medico ha eseguito oltre 1.400–2.000 interventi di Chirurgia Micrografica di Mohs, raggiungendo tassi di guarigione superiori ai metodi tradizionali. Il medico è anche esperto in Terapia Fotodinamica, Screening del Cancro della Pelle e gestione delle IST.
Il medico è membro di diverse società prestigiose e ha una valutazione media di 4.9/5 su TopDoctors e 9.9/10 su AiroMedical.
Il medico è specializzato nel trattamento del cancro al seno e endocrino, concentrandosi sul superamento della resistenza alla terapia ormonale durante la malattia adiuvante e metastatica. Attivamente coinvolto in studi di fase 1, 2 e 3 per il cancro al seno e il melanoma, il medico ha contribuito all'approvazione di nuovi farmaci, inclusi inibitori di cdk4/6 come palbociclib e ribociclib per il cancro al seno metastatico, e trattamenti di immunoterapia come Pembrolizumab, Nivolumab e Ipilimumab per il melanoma. Il medico è membro dell'Unità di Cancro al Seno e dell'Unità di Melanoma presso l'Ospedale Universitario Vall d’Hebron e l'Istituto di Oncologia Vall d’Hebron.<\/p>
Il medico possiede una laurea in Medicina presso l'Università Complutense di Madrid e un dottorato presso l'Università di Barcellona. Specializzandosi in Ematologia e Oncologia Pediatrica presso l'Università del Maryland, il medico è esperto nel trattamento di tumori ossei e cerebrali, nonché di leucemia e malattie ematologiche.<\/p>
Con oltre due decenni di esperienza, il medico attualmente dirige l'Unità di Ematologia e Oncologia Pediatrica presso l'Ospedale HM Montepríncipe, concentrandosi sulla cura di bambini e adolescenti. In precedenza, il medico ha ricoperto la stessa posizione presso l'Ospedale Universitario Clínica San Rafael ed è autore di numerose pubblicazioni scientifiche.<\/p>
Spanish oncology centers provide advanced melanoma surgeries like Mohs micrographic surgery and robot-assisted procedures. Specialists use sentinel lymph node biopsy for precise staging. These methods are available at JCI-accredited facilities in Barcelona and Madrid. Surgeons maintain high success rates using international oncology protocols.
Bookimed Expert Insight: Spain ranks 5th globally for medical tourism on Bookimed, largely driven by concentrated expertise in Barcelona. Dr. Joan Ramon Garces Gatnau at Centro Médico Teknon has performed over 2,000 Mohs surgeries. This high volume is rare, as many surgeons across Europe only offer standard wide excision. Choosing a high-volume specialist in Barcelona often ensures access to these refined, tissue-sparing techniques.
Patient Consensus: Patients note that seeking treatment in Madrid or Barcelona provides much faster access to specialized surgeons. They emphasize that private clinics significantly reduce wait times which is critical for early-stage staging.
International patients can access advanced immunotherapy and targeted therapy for melanoma at private Spanish hospitals. Centers like Centro Medico Teknon and Quironsalud Madrid offer checkpoint inhibitors and molecular diagnostics. Most facilities require proof of private insurance or out-of-pocket payments for non-resident access.
Bookimed Expert Insight: While many patients focus on drug availability, the real advantage in Spain is the volume of clinical research. Specialists like Dr. Jesus Soberino at Hospital Quiron Barcelona have directly led trials for major immunotherapies. This high level of academic involvement means private patients often receive protocols refined by the very doctors who helped approve them.
Patient Consensus: Patients emphasize the need to bring complete pathology records in English to avoid repeating expensive scans. Those treated in Madrid and Barcelona report much smoother communication due to better English-speaking staff at private oncology units.
Recovery after melanoma surgery in Spain typically takes 2 to 4 weeks for standard excisions. Initial wound healing occurs within 14 days. Full outcomes for incision lines and redness may take up to 1 year. Surgeons often remove stitches between 5 and 14 days post-operation.
Bookimed Expert Insight: Spain offers a unique advantage for melanoma patients through specialized units like the Baselga Institute at Hospital Quiron Barcelona. Data shows these centers integrate clinical trials directly into treatment plans. This means patients often access emerging immunotherapy protocols, like Pembrolizumab combinations, alongside standard surgical recovery. Choosing a JCI-accredited facility in Barcelona or Madrid ensures these advanced monitoring technologies are consolidated in one location.
Patient Consensus: Patients note that while the physical wound heals quickly, managing the monthly skin photo diary and regular surveillance visits is vital. Many emphasize that private clinics in Spain provide much faster scheduling for follow-up scans than the public system.
Spanish hospitals like Clinica Universidad de Navarra and Centro Médico Teknon hold prestigious Joint Commission International (JCI) accreditation for melanoma care. These facilities provide advanced surgical techniques. They also offer modern immunotherapy protocols. Leading centers often hold European Society for Medical Oncology certifications.
Bookimed Expert Insight: Spanish oncology centers show a strong trend of specialization. Clinica Universidad de Navarra maintains a 95% limb preservation rate. This is exceptional for complex melanoma cases. Choosing a center with high procedural volume is key. Centro Médico Teknon serves 10,000 patients annually. Highly active hospitals typically offer faster access to specialized Mohs micrographic surgery.
Patient Consensus: Patients note that finding a surgeon experienced in sentinel lymph node biopsy is vital. They often recommend private facilities to avoid wait times for suspicious lesions.
Non-resident patients can access clinical trials for melanoma drugs in Spain if they meet strict eligibility criteria. Major research centers in Madrid and Barcelona frequently enroll international participants for phase 1-3 trials. Patients must usually cover travel, diagnostics, and lodging expenses while study medications are provided at no cost.
Bookimed Expert Insight: Spanish oncology centers like Clinica Universidad de Navarra maintain exceptionally high international patient volumes, treating over 700,000 people from 70 countries. Our data shows that while trials offer the drug for free, pre-trial diagnostics in Spain can be significant. For instance, immunotherapy packages at top clinics like Teknon Medical Center start around $13,400 just for the medication and basic staging. Always confirm if the trial covers PET-CT and BRAF gene mutation testing, as these costs typically fall on the patient.
Patient Consensus: Patients note that non-EU residents often face bureaucractic hurdles with medical visas. Many recommend budgeting between $5,500 and $16,000 for initial workups and local advocacy to improve enrollment chances.
English-speaking melanoma patients in Spain access support through regional charities and specialized units in JCI-accredited hospitals. Organizations like MABS and Cancer Support Group Mallorca provide translation, transport, and counseling. Private centers like Centro Médico Teknon offer English-speaking coordinators and medical specialists to manage international cases.
Bookimed Expert Insight: Spain ranks 5th globally for medical requests, reflecting its status as a preferred hub for complex oncology. Our data shows hospitals like Hospital Quiron Barcelona and Clinica Universidad de Navarra handle high patient volumes, sometimes reaching 700,000 international cases annually. Selecting a center with historical JCI accreditation ensures that administrative support and medical safety meet rigorous international standards for non-Spanish speakers.
Patient Consensus: Patients note that while public hospitals have modern equipment, the language barrier makes private clinics or expat-led WhatsApp groups essential for emotional support. Many emphasize that a proactive approach is necessary because formal English-language support materials from local NGOs are often limited.